Abstract

Background: Existing standardized biofilm assays focus on simple mono-species or bacterial-only models. Incorporating Candida albicans into complex biofilm models can offer a more appropriate and relevant polymicrobial biofilm for the development of oral health products. Aims: This study aimed to assess the importance of interkingdom interactions in polymicrobial oral biofilm systems with or without C. albicans, and test how these models respond to oral therapeutic challenges in vitro. Materials and Methods: Polymicrobial biofilms (two models containing 5 and 10 bacterial species, respectively) were created in parallel in the presence and absence of C. albicans and challenged using clinically relevant antimicrobials. The metabolic profiles and biomasses of these complex biofilms were estimated using resazurin dye and crystal violet stain, respectively. Quantitative PCR was utilized to assess compositional changes in microbial load. Additional assays, for measurements of pH and lactate, were included to monitor fluctuations in virulence “biomarkers.” Results: An increased level of metabolic activity and biomass in the presence of C. albicans was observed. Bacterial load was increased by more than a factor of 10 in the presence of C. albicans. Assays showed inclusion of C. albicans impacted the biofilm virulence profiles. C. albicans did not affect the biofilms’ responses to the short-term incubations with different treatments. Conclusions: The interkingdom biofilms described herein are structurally robust and exhibit all the hallmarks of a reproducible model. To our knowledge, these data are the first to test the hypothesis that yeasts may act as potential “keystone” components of oral biofilms.

Highlights

  • Existing standardized biofilm assays focus on simple mono-species or bacterial-only models

  • Multi-species biofilms were grown in parallel in the presence or absence of C. albicans to determine the change to the overall metabolic rate and biomass of biofilms following incorporation of Candida (Figure 1)

  • Candida albicans is known as an opportunistic pathogen which colonizes many different sites of the human body, with an ability to cause severe disease through candidiasis in the immunocompromized [64]

Read more

Summary

Results

Biomass and Compositional Profiles of Oral Biofilm Models with or without C. albicans. The results indicate that both metabolic activity and biomass were significantly increased upon the inclusion of C. albicans in both hard (HT). The fluorescence readings illustrating metabolic activity showed that HT biofilms increased by 2.8-fold, the mean output reading went from. ST biofilms showed a 1.8-fold increase in metabolic activity when C. albicans was present, increasing from ~27,000 to ~50,000 Au. In a similar trend, the biomasses of the oral biofilm models were significantly increased when Candida was included; HT biofilms increased almost 4-fold from an average O.D. of. ~0.5 to ~2.0; and ST associated biofilm increased from ~0.8 O.D. to ~2.0, a 2.5-fold increase (Figure 1B) Overall, this data highlighted a thicker biofilm which is more metabolically active when C. albicans was present, in both models tested

Introduction
Growth and Standardization of Bacteria
Development of Multi-Species Biofilms
Testing of Oral Models
Metabolic Analysis of Oral Biofilms
Assessment of Oral Biofilms Biomass
Quantitative Analysis of Biofilm Composition
Visualization of Oral Biofilms
2.10. Assays to Assess Pathogenicity of the Oral Biofilms
2.11. Treatment of Oral Biofilms
2.12. Statistical Analysis and Data Presentation
59 PEER REVIEW
Bacterial load following min treatment hard and tissue biofilms plus or minus
Discussion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call